Cargando…
Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control
Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183521/ https://www.ncbi.nlm.nih.gov/pubmed/25275393 http://dx.doi.org/10.1371/journal.pone.0108916 |
_version_ | 1782337704220950528 |
---|---|
author | Hamlyn, John M. Linde, Cristina I. Gao, Junjie Huang, Bing S. Golovina, Vera A. Blaustein, Mordecai P. Leenen, Frans H. H. |
author_facet | Hamlyn, John M. Linde, Cristina I. Gao, Junjie Huang, Bing S. Golovina, Vera A. Blaustein, Mordecai P. Leenen, Frans H. H. |
author_sort | Hamlyn, John M. |
collection | PubMed |
description | Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained phase of hypertension is associated also with elevated circulating levels of endogenous ouabain (EO), and chronic stimulation of arterial calcium transport proteins including the sodium-calcium exchanger (NCX1), the type 6 canonical transient receptor potential protein (TRPC6), and the sarcoplasmic reticulum calcium ATPase (SERCA2). Wistar rats received a chronic intra-cerebroventricular infusion of vehicle (C) or Ang II (A, 2.5 ng/min, for 14 days) alone or combined with the MR blocker, eplerenone (A+E, 5 µg/day), or the aldosterone synthase inhibitor, FAD286 (A+F, 25 µg/day). Conscious mean BP increased (P<0.05) in A (123±4 mm Hg) vs all other groups. Blood, pituitary and adrenal samples were taken for EO radioimmunoassay (RIA), and aortas for NCX1, TRPC6 and SERCA2 immunoblotting. Central infusion of Ang II raised plasma EO (0.58±0.08 vs C 0.34±0.07 nM (P<0.05), but not in A + E and A + F groups as confirmed by off-line liquid chromatography (LC)-RIA and LC-multistage mass spectrometry. Two novel isomers of EO were elevated by Ang II; the second less polar isomer increased >50-fold in the A+F group. Central Ang II increased arterial expression of NCX1, TRPC6 and SERCA2 (2.6, 1.75 and 3.7-fold, respectively; P<0.01)) but not when co-infused with E or F. Adrenal and pituitary EO were unchanged. We conclude that brain Ang II activates a CNS-humoral axis involving plasma EO. The elevated EO reprograms peripheral ion transport pathways known to control arterial Na(+) and Ca(2+) homeostasis; this increases contractility and augments sympathetic effects. The new axis likely contributes to the chronic pressor effect of brain Ang II. |
format | Online Article Text |
id | pubmed-4183521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41835212014-10-07 Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control Hamlyn, John M. Linde, Cristina I. Gao, Junjie Huang, Bing S. Golovina, Vera A. Blaustein, Mordecai P. Leenen, Frans H. H. PLoS One Research Article Central nervous system (CNS) administration of angiotensin II (Ang II) raises blood pressure (BP). The rise in BP reflects increased sympathetic outflow and a slower neuromodulatory pressor mechanism mediated by CNS mineralocorticoid receptors (MR). We investigated the hypothesis that the sustained phase of hypertension is associated also with elevated circulating levels of endogenous ouabain (EO), and chronic stimulation of arterial calcium transport proteins including the sodium-calcium exchanger (NCX1), the type 6 canonical transient receptor potential protein (TRPC6), and the sarcoplasmic reticulum calcium ATPase (SERCA2). Wistar rats received a chronic intra-cerebroventricular infusion of vehicle (C) or Ang II (A, 2.5 ng/min, for 14 days) alone or combined with the MR blocker, eplerenone (A+E, 5 µg/day), or the aldosterone synthase inhibitor, FAD286 (A+F, 25 µg/day). Conscious mean BP increased (P<0.05) in A (123±4 mm Hg) vs all other groups. Blood, pituitary and adrenal samples were taken for EO radioimmunoassay (RIA), and aortas for NCX1, TRPC6 and SERCA2 immunoblotting. Central infusion of Ang II raised plasma EO (0.58±0.08 vs C 0.34±0.07 nM (P<0.05), but not in A + E and A + F groups as confirmed by off-line liquid chromatography (LC)-RIA and LC-multistage mass spectrometry. Two novel isomers of EO were elevated by Ang II; the second less polar isomer increased >50-fold in the A+F group. Central Ang II increased arterial expression of NCX1, TRPC6 and SERCA2 (2.6, 1.75 and 3.7-fold, respectively; P<0.01)) but not when co-infused with E or F. Adrenal and pituitary EO were unchanged. We conclude that brain Ang II activates a CNS-humoral axis involving plasma EO. The elevated EO reprograms peripheral ion transport pathways known to control arterial Na(+) and Ca(2+) homeostasis; this increases contractility and augments sympathetic effects. The new axis likely contributes to the chronic pressor effect of brain Ang II. Public Library of Science 2014-10-02 /pmc/articles/PMC4183521/ /pubmed/25275393 http://dx.doi.org/10.1371/journal.pone.0108916 Text en © 2014 Hamlyn et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hamlyn, John M. Linde, Cristina I. Gao, Junjie Huang, Bing S. Golovina, Vera A. Blaustein, Mordecai P. Leenen, Frans H. H. Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control |
title | Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control |
title_full | Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control |
title_fullStr | Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control |
title_full_unstemmed | Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control |
title_short | Neuroendocrine Humoral and Vascular Components in the Pressor Pathway for Brain Angiotensin II: A New Axis in Long Term Blood Pressure Control |
title_sort | neuroendocrine humoral and vascular components in the pressor pathway for brain angiotensin ii: a new axis in long term blood pressure control |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183521/ https://www.ncbi.nlm.nih.gov/pubmed/25275393 http://dx.doi.org/10.1371/journal.pone.0108916 |
work_keys_str_mv | AT hamlynjohnm neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol AT lindecristinai neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol AT gaojunjie neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol AT huangbings neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol AT golovinaveraa neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol AT blausteinmordecaip neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol AT leenenfranshh neuroendocrinehumoralandvascularcomponentsinthepressorpathwayforbrainangiotensiniianewaxisinlongtermbloodpressurecontrol |